Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT6 | Q96LA8 | 3/20 | 0.52 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.52 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.52 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.52 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.52 |
| ▸ | CCR3 | P51677 | 2/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.49 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.49 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.49 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.49 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.49 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.49 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.49 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.49 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6009487 | 0.88 | GRIN2D (0.56) | PRMT6CARM1PRMT3PRMT1PRMT8 | |
| Hydrochloric Acid SCHEMBL6009329 | 0.87 | GRIN2D (0.55) | PRMT6CARM1PRMT3PRMT1PRMT8 | |
| SCHEMBL6007510 | 0.82 | CYP2J2 (0.45) | ADRA1DADRA1AADRA1BKCNH2 | |
| SCHEMBL5914324 | 0.82 | CCR3 (0.62) | PRMT6CARM1PRMT3PRMT1PRMT8 | |
| SCHEMBL5914355 | 0.82 | CCR3 (0.62) | PRMT6CARM1PRMT3PRMT1PRMT8 | |
| SCHEMBL6007996 | 0.81 | MEN1 (0.55) | ADRA1DADRA1AADRA1BKCNH2 | |
| SCHEMBL20306196 | 0.79 | SIGMAR1 (0.78) | CCR3KCNH2SIGMAR1 | |
| SCHEMBL18590360 | 0.78 | KCNH2 (0.71) | CCR3GRIN2DGRIN3BADRA1DADRA1A | |
| SCHEMBL17023759 | 0.78 | KCNH2 (0.71) | CCR3GRIN2DGRIN3BADRA1DADRA1A | |
| SCHEMBL18609512 | 0.77 | SLC6A2 (0.57) | CCR3GRIN2DGRIN3BADRA1DADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7078537-B2 | Phenylalkyl diamine and amide analogs | SK CORPORATION (KR) | 2006-07-18 | — | — | US | claimed |
| US-20030105079-A1 | Novel phenylalkyl diamine and amide analogs | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2003-06-05 | — | — | US | claimed |
| US-7078537-B2 | Phenylalkyl diamine and amide analogs | SK CORPORATION (KR) | 2006-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105079-A1 | Novel phenylalkyl diamine and amide analogs | SIGMAR1, TAAR1, OPRL1 | PRMT6 1600/4885CARM1 4111/4885PRMT3 1405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.